Restricted accessResearch articleFirst published online 2020-1
Changes in Positive and Negative Affect During Pharmacological Treatment and Cognitive Therapy for Major Depressive Disorder: A Secondary Analysis of Two Randomized Controlled Trials
The cardinal symptoms of major depressive disorder (MDD) are heightened depressed mood (negative affectivity, or NA) and diminished interest or pleasure (positive affectivity, or PA). It is unknown how well treatments for MDD repair either symptom. Two secondary analyses of randomized controlled trials were therefore conducted. In Study 1, 180 adult outpatients with MDD received 16 weeks of antidepressant medication (ADM; n = 120) or cognitive therapy (CT; n = 60). In Study 2, adult outpatients with MDD were treated until remission with ADM (n = 225) or ADM and CT (n = 227). Across trials and treatments, intake disturbances were more marked in PA than NA, there was smaller repair of PA than NA during treatment, and disturbances remained more pronounced for PA than NA after treatment. Greater change in PA and NA were independently associated with depression symptom change. These findings suggest that depression treatments more effectively repair NA than PA and that outcomes may be improved with more effective targeting of the latter.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Rev.). Washington, DC: Author.
2.
AndersonI. M.FerrierI. N.BaldwinR. C.CowenP. J.HowardL.LewisG.. . . TyleeA. (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 22, 343–396.
3.
ArgyropoulosS. V.NuttD. J. (2013). Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?Journal of Psychopharmacology, 27, 869–877.
4.
BeckA. T.FreemanA. (1990). Cognitive therapy of personality disorders. New York, NY: Guilford Press.
5.
BeckA. T.RushA. J.ShawB. F.EmeryG. (Ed.). (1979). Cognitive therapy of depression. New York, NY: Guilford Press.
6.
BeckJ. S. (1995). Cognitive therapy: Basics and beyond. New York, NY: Guilford Press.
7.
BedfordA. (1997). On Clark-Watson’s tripartite model of anxiety and depression. Psychological Reports, 80, 125–126.
8.
BerridgeK. C.KringlebachM. L. (2008). Affective neuroscience of pleasure: Reward in humans and animals. Psychopharmacology, 199, 457–480.
9.
BlozisS. A.ChoY. (2008). Coding and centering of time in latent curve models in the presence of interindividual time heterogeneity. Structural Equation Modelling: A Multidisciplinary Journal, 15, 413–433.
10.
BorsboomD. (2017). A network theory of mental disorders. World Psychiatry, 16, 5–13.
11.
BoumparisN.KaryotakiE.KleiboerA.HofmannS. G.CuijpersP. (2016). The effect of psychotherapeutic interventions on positive and negative affect in depression: A systematic review and meta-analysis. Journal of Affective Disorders, 202, 153–162.
12.
BrownT. A. (2007). Temporal course and structural relationships among dimensions of temperament and DSM-IV anxiety and mood disorder constructs. Journal of Abnormal Psychology, 116, 313–328.
13.
BurrL. A.JavaidM.JellG.Werner-SeidlerA. (2017). Turning lemonade into lemons: Dampening appraisals reduce positive affect and increase negative affect during positive activity scheduling. Behaviour Research and Therapy, 91, 91–101.
14.
ButtonK. S.KounaliD.ThomasL.WilesN. J.PetersT. J.WeltonN. J.. . . LewisG. (2015). Minimum clinically important difference on the Beck Depression Inventory – II according to the patient’s perspective. Psychological Medicine, 45, 3269–3279.
15.
ChavesC.Lopez-GomezI.HervasG.VazquezC. (2017). A comparative study on the efficacy of a positive psychology intervention and a cognitive behavioural therapy for clinical depression. Cognitive Therapy and Research, 41, 417–433.
16.
CohenJ. (1988). Statistical power analysis for the behavioural sciences. New York, NY: Academic Press.
17.
CraskeM.MeuretA. E.RitzT.TreanorM.DourH.RosenfieldD. (2019). Positive affect treatment for depression and anxiety. A randomized controlled trial for a core feature of anhedonia. Journal of Consulting and Clinical Psychology, 87, 457–471.
18.
CrawfordJ. R.GarthwaiteP. H.LawrieC. J.HenryJ. D.MacDonaldM. A.SutherlandJ.SinhaP. (2009). A convenient method of obtaining percentile norms and accompanying interval estimates for self-report mood scales (DASS, DASS-21, HADS, PANAS, and sAD). British Journal of Clinical Psychology, 48, 163–180.
19.
CuijpersP.BerkingM.AnderssonG.QuigleyL.KleiboerA.DobsonK. S. (2013). A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. The Canadian Journal of Psychiatry, 58, 376–385.
20.
CuijpersP.KaryotakiE.WeitzE.AnderssonG.HollonS. D.van StratenA. (2014). The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. Journal of Affective Disorders, 159, 118–126.
21.
CuijpersP.van StratenA.AnderssonG.van OppenP. (2008). Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies. Journal of Consulting and Clinical Psychology, 76, 909–922.
22.
DemyttenaereK.DonneauA. F.AlbertA.AnsseauM.ConstantE.Van HeeringenK. (2015). What is important in being cured from depression? Discordance between physicians and patients (1). Journal of Affective Disorders, 174, 390–396.
23.
DeRubeisR. J.HollonS. D.AmsterdamJ. D.SheltonR. C.YoungP. R.SalomonR. M.. . . GallopR. (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62, 409–416.
24.
DunlopB. W.NemeroffC. B. (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry, 64, 327–337.
25.
DunnB. D. (2012). Helping depressed clients reconnect to positive emotion experience: Current insights and future directions. Clinical Psychology & Psychotherapy, 19, 326–340.
26.
DunnB. D. (2017). Opportunities and challenges for the emerging field of positive emotion regulation: A commentary on the special edition on positive emotions and cognitions in clinical psychology. Cognitive Therapy & Research, 41, 469–478.
27.
DunnB. D. (2019). Augmenting cognitive behavioural therapy to build positive mood in depression. In GruberJ. (Ed.), Oxford handbook of positive emotion and psychopathology (pp. 539–560). Oxford, England: Oxford University Press.
28.
DunnB. D.BurrL. A.SmithH. B.HuntA.DadgostarD.DalglishL.. . . Werner-SeidlerA. (2018) Turning gold into lead: Dampening appraisals reduce happiness and pleasantness and increase sadness during anticipation and recall of pleasant activities in the laboratory. Behaviour Research and Therapy, 107, 19–33.
29.
DunnB. D.RobertsH. (2016). Improving the capacity to treat depression using talking therapies. In WoodA. M.JohnsonJ. (Ed.), The Wiley handbook of positive clinical psychology (pp. 183–204). Hoboken, NJ: John Wiley & Sons.
30.
DunnB. D.WidnallE. W.ReedN.TaylorR. S.OwensC.SpencerA.. . . KuykenW. (2019). Evaluating Augmented Depression Therapy (ADepT): Study protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies, 5, Article 63. doi:10.1186/s40814-019-0438-1
31.
FawcettJ.ScheftnerW. A.FoggL.ClarkD. C.YoungM. A. (1990). Time-related predictors of suicide in major affective disorder. The American Journal of Psychiatry, 147, 1189–1194.
32.
FriedE. I.EpskampS.NesseR. M.TuerlinckxF.BorsboomD. (2016). What are “good” depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. Journal of Affective Disorders, 189, 314–320.
33.
FriedE. I.NesseR. M. (2014). The impact of individual depressive symptoms on impairment of psychosocial functioning. PLOS ONE, 9, Article e90311. doi:10.1371/journal.pone.0090311
34.
FriedE. I.van BorkuloC. D.CramerA. O. J.BoschlooL.SchoeversR. A.BorsboomD. (2017). Mental disorders as networks of problems: A review of recent insights. Social Psychiatry and Psychiatric Epidemiology, 51, 1–10.
35.
GadeikisD.BosN.SchweizerS.MurphyF.DunnB. D. (2017). Engaging in an experiential processing mode increases positive emotional response during recall of pleasant autobiographical memories. Behaviour Research and Therapy, 92, 68–76.
36.
GeschwindN.ArntzA.BanninkF.PeetersF. (2019). Positive cognitive behaviour therapy in the treatment of depression: A randomized order within-subject comparison with traditional cognitive behaviour therapy. Behaviour Research and Therapy, 116, 119–130.
37.
GeschwindN.NicolsonN. A.PeetersF.van OsJ.Barge-SchaapveldD.WichersM. (2011). Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy. European Neuropsychopharmacology, 21, 241–247.
38.
GrayJ. A. (1987). The psychology of fear and stress. New York, NY: McGraw-Hill.
39.
HamiltonM. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62.
40.
HofmannS. G.CurtissJ.McNallyR. J. (2016). A complex network perspective on clinical science. Perspectives in Psychological Science, 11, 597–605.
41.
HofmannS. G.HayesS. C. (2019). The future of intervention science: Process-based therapy. Clinical Psychological Science, 7, 37–50.
42.
HollonS. D.DeRubeisR. J.FawcettJ.AmsterdamJ. D.SheltonR. C.ZajeckaJ.. . . GallopR. (2014). Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA: Psychiatry, 71, 1157–1164.
43.
HunotV.MooreT. H. M.CaldwellD. M.DaviesP.JonesH.HonyashikiM.. . . ChurchillR. (2013). “Third wave” cognitive and behavioural therapies versus other psychological therapies for depression. Cochrane Database of Systematic Reviews 2013, Issue 10. Article CD008704. doi:10.1002/14651858.CD008704.pub2.
44.
InselT.CuthbertB.GarveyM.HeinssenR.PineD. S.QuinnK.. . . WangP. (2010). Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. American Journal of Psychiatry, 167, 748–751.
45.
JacobsonN. S.TruaxP. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy. Journal of Consulting and Clinical Psychology, 59, 12–19
46.
JamersonB. D.KrishnanK. R.RobertsJ.KrishenA.ModellJ. G. (2003). Effect of bupropion SR on specific symptom clusters of depression: Analysis of the 31-item Hamilton Rating Scale for depression. Psychopharmacology Bulletin, 37, 67–78.
47.
JamiesonJ. (2004). Analysis of covariance (ANCOVA) with difference scores. International Journal of Psychophysiology, 52, 277–283.
48.
KendallA. D.ZinbargR. E.BobovaL.MinekaS.RevelleW.ProveauJ. M.CraskeM. G. (2016). Measuring positive emotion with the mood and anxiety symptom questionnaire: Psychometric properties of the anhedonic depression scale. Assessment, 23, 86–95.
49.
KeoghE.ReidyJ. (2000). Exploring the factor structure of the Mood and Anxiety Symptom Questionnaire (MASQ). Journal of Personality Assessment, 74, 106–125.
50.
KesslerR. C.BerglundP.DemlerO.JinR.KoretzD.MerikangasK. R.. . . WangP. S. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA: Journal of the American Medical Association, 289, 3095–3105.
51.
KringA. M.PersonsJ. B.ThomasC. (2007). Changes in affect during treatment for depression and anxiety. Behaviour Research and Therapy, 45, 1753–1764.
52.
LallyN.NugentA. C.LuckenbaughD. A.NiciuM. J.RoiserJ. P.ZarateC. A.Jr. (2015). Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. Journal of Psychopharmacology, 29, 596–607.
53.
MartellC. R.DimidjianS.Herman-DunnR. (2010). Behavioral activation for depression: A clinician’s guide. New York, NY: Guilford Press.
54.
McMakinD. L.OlinoT. M.PortaG.DietzL. J.EmslieG.ClarkeG.. . . ShamseddeenW. (2012). Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment–resistant depression. Journal of the American Academy of Child & Adolescent Psychiatry, 51, 404–411.
55.
Naragon-GaineyK.GallagherM. W.BrownT. A. (2013). Stable “trait” variance of temperament as a predictor of the temporal course of depression and social phobia. Journal of Abnormal Psychology, 122, 611–623.
56.
NormanG. R.SloanJ. A.WyrwichK. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.
57.
PaulusM. P.SteinM. B.CraskeM. G.BookheimerS.TaylorC. T.SimmonsA. N.. . . FanB. (2017). Latent variable analysis of positive and negative valence processing focused on symptom and behavioural units of analysis in mood and anxiety disorders. Journal of Affective Disorders, 216, 17–29.
58.
PaunonenS. V. (2003). Big Five factors of personality and replicated predictions of behavior. Journal of Personality and Social Psychology, 84, 411–424.
59.
PriceJ.ColeV.GoodwinG. M. (2009). Emotional side-effects of selective serotonin reuptake inhibitors: Qualitative study. The British Journal of Psychiatry, 195, 211–217.
60.
ProvencherH. L.KeyesC. L. M. (2011). Complete mental health recovery: Bridging mental illness with positive mental health. Journal of Public Mental Health, 10, 57–69.
61.
RichardsD. A.EkersD.McMillanD.TaylorR. S.ByfordS.WarrenF. C.. . . O’MahenH. (2016). Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): A randomised, controlled, non-inferiority trial. The Lancet, 388, 871–880.
62.
RobertsB. W.LuoJ.BrileyD. A.ChowP. I.SuR.HillP. L. (2017). A systematic review of personality trait change through intervention. Psychological Bulletin, 143, 117–141.
63.
RuiniC.FavaG. A. (2012). Role of well-being therapy in achieving a balanced and individualized path to optimal functioning. Clinical Psychology & Psychotherapy, 19, 291–304.
64.
RushA. J. (2015). Distinguishing functional from syndromal recovery: Implications for clinical research and practice. Journal of Clinical Psychiatry, 76, e832–e834.
65.
RushA. J.KraemerH. C.SackheimH. A.FavaM.TrivediM. H.FrankE.. . . ACNP Task Force. (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology, 31, 1841–1853.
66.
RushA. J.TrivediM. H.WisniewskiS. R.NierenbergA. A.StewartJ. W.WardenD.. . . McGrathP. J. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. American Journal of Psychiatry, 163, 1905–1917.
67.
SchimmackU.OishiS.FurrR. M.FunderD. C. (2004). Personality and life satisfaction: A facet-level analysis. Personality and Social Psychology Bulletin, 30, 1062–1075.
68.
SheehanD. V.Harnett-SheehanK.SpannM. E.ThompsonH. F.PrakashA. (2011). Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. International Clinical Psychopharmacology, 26, 75–83.
69.
SheehanD. V.NakagomeK.AsamiY.PappadopulosE. A.BoucherM. (2017). Restoring function in major depressive disorder: A systematic review. Journal of Affective Disorders, 215, 299–313.
70.
SheltonR. C.TomarkenA. J. (2001). Can recovery from depression be achieved?Psychiatric Services, 52, 1469–1478.
71.
SladeM. (2010). Mental illness and well-being: The central importance of positive psychology and recovery approaches. BMC Health Services Research, 10, Article 26. doi:10.1186/1472-6963-10-26
72.
SnaithR. P.HamiltonM.MorleyS.HumayanA.HargreavesD.TrigwellP. (1995). A scale for the assessment of hedonic tone the Snaith–Hamilton Pleasure Scale. The British Journal of Psychiatry, 167, 99–103.
73.
SpijkerJ.BijlR. V.De GraafR.NolenW. A. (2001). Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatrica Scandinavica, 103, 122–130.
74.
TomarkenA. J.DichterG. S.FreidC.AddingtonS.SheltonR. C. (2004). Assessing the effects of bupropion SR on mood dimensions of depression. Journal of Affective Disorders, 78, 235–241.
75.
TomarkenA. J.SheltonR. C.HollonS. D. (2007). Affective science as a framework for understanding the mechanisms and effects of antidepressant medications. In RottenbergJ.JohnsonS. L. (Eds.), Emotion and psychopathology: Bridging affective and clinical science (pp. 263–283). Washington, DC: American Psychological Association.
76.
TreadwayM. T.ZaldD. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience & Biobehavioral Reviews, 35, 537–555.
77.
UherR.PerlisR. H.HenigsbergN.ZobelA.RietschelM.MorsO.. . . MaierW. (2012). Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychological Medicine, 42, 967–980.
78.
ÜstünT. B.Ayuso-MateosJ. L.ChatterjiS.MathersC.MurrayC. J. (2004). Global burden of depressive disorders in the year 2000. The British Journal of Psychiatry, 184, 386–392.
79.
van BorkuloC.BoschiooL.BorsboomD.PenninxB. W.WaldorpL. J.SchoeversR. A. (2015). Association of symptom network structure with the course of depression. JAMA Psychiatry, 72, 1219–1226.
80.
VittenglJ. R.ClarkL. A.DunnT. W.JarrettR. B. (2007). Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy’s effects. Journal of Consulting and Clinical Psychology, 75, 475–488.
81.
WangL.MaxwellS. E. (2015). On disaggregating between-person and within-person effects with longitudinal data using multilevel models. Psychological Methods, 20, 63–83.
82.
WatsonD.ClarkL. A. (1991). The Mood and Anxiety Symptom Questionnaire. Unpublished manuscript, Department of Psychology, University of Iowa, Iowa City.
83.
WatsonD.ClarkL. A. (1999). The PANAS-X: Manual for the Positive and Negative Affect Schedule–Expanded form. Iowa City, IA: University of Iowa.
84.
WatsonD.ClarkL. A.CareyG. (1988). Positive and negative affectivity and their relation to anxiety and depressive disorders. Journal of Abnormal Psychology, 97, 346–353.
85.
WatsonD.ClarkL. A.TellegenA. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54, 1063–1070.
86.
WatsonD.Naragon-GaineyK. (2014). Personality, emotions and the emotional disorders. Clinical Psychological Science, 2, 422–442.
87.
WatsonD.StasikS. M.Ellickson-LarewS.StantonK. (2015). Extraversion and psychopathology: A facet level analysis. Journal of Abnormal Psychology, 124, 432–446.
88.
WatsonD.WieseD.VaidyaJ.TellegenA. (1999). The two general activation systems of affect: Structural findings, evolutionary considerations, and psychobiological evidence. Journal of Personality and Social Psychology, 76, 820–838.
89.
WhiteI. R.RoystonP.WoodA. M. (2011). Multiple imputation using chained equations: Issues and guidance for practice. Statistics in Medicine, 30, 377–399.
90.
WilesN.ThomasL.AbelA.RidgwayN.TurnerN.CampbellJ.. . . KuykenW. (2013). Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: Results of the CoBalT randomised controlled trial. The Lancet, 381, 375–384.
91.
ZimmermanM.McGlincheyJ. B.PosternakM. A.FriedmanM.AttiullahN.BoerescuD. (2006). How should remission from depression be defined? The depressed patient’s perspective. American Journal of Psychiatry, 163, 148–150.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
